Gene · 4060
Papers3,622
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 3,622
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Heteromerization between α1B -adrenoceptor and chemokine (C-C motif) receptor 2 biases α1B -adrenoceptor signaling: Implications for vascular function. | FEBS Lett | 2022 | 35920096 | PubTator, text mining | PubMed |
| Characterizing intrinsic molecular features of the immune subtypes of salivary mucoepidermoid carcinoma. | Transl Oncol | 2022 | 35917642 | PubTator, text mining | PubMed |
| Single cell multi-omics characterise discrete human tendon cells populations that persist in vitro and on fibrous scaffolds. | Eur Cell Mater | 2022 | 35916474 | PubTator, text mining | PubMed |
| A Knowledge-Based Discovery Approach Couples Artificial Neural Networks With Weight Engineering to Uncover Immune-Related Processes Underpinning Clinical Traits of Breast Cancer. | Front Immunol | 2022 | 35911770 | PubTator, text mining | PubMed |
| Role of Caveolin-1 in Sepsis - A Mini-Review. | Front Immunol | 2022 | 35911737 | PubTator, text mining | PubMed |
| Study on Proteomics-Based Aortic Dissection Molecular Markers Using iTRAQ Combined With Label Free Techniques. | Front Physiol | 2022 | 35910577 | PubTator, text mining | PubMed |
| Construction and Verification of a Fibroblast-Related Prognostic Signature Model for Colon Cancer. | Front Genet | 2022 | 35910200 | PubTator, text mining | PubMed |
| The impact of neoadjuvant chemotherapy on the tumor microenvironment in advanced high-grade serous carcinoma. | Oncogenesis | 2022 | 35907904 | PubTator, text mining | PubMed |
| Mouse fetal growth restriction through parental and fetal immune gene variation and intercellular communications cascade. | Nat Commun | 2022 | 35906236 | PubTator, text mining | PubMed |
| Transcriptomic Profiling of Human Limbus-Derived Stromal/Mesenchymal Stem Cells-Novel Mechanistic Insights into the Pathways Involved in Corneal Wound Healing. | Int J Mol Sci | 2022 | 35897793 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing depicts the local cell landscape in thyroid-associated ophthalmopathy. | Cell Rep Med | 2022 | 35896115 | PubTator, text mining | PubMed |
| Differential Protein Expression among Two Different Ovine ARDS Phenotypes-A Preclinical Randomized Study. | Metabolites | 2022 | 35888779 | PubTator, text mining | PubMed |
| Human SMILE-Derived Stromal Lenticule Scaffold for Regenerative Therapy: Review and Perspectives. | Int J Mol Sci | 2022 | 35887309 | PubTator, text mining | PubMed |
| Stage II of Chronic Kidney Disease-A Tipping Point in Disease Progression? | Biomedicines | 2022 | 35884827 | PubTator, text mining | PubMed |
| An Integrated Bioinformatics Analysis towards the Identification of Diagnostic, Prognostic, and Predictive Key Biomarkers for Urinary Bladder Cancer. | Cancers (Basel) | 2022 | 35884419 | PubTator, text mining | PubMed |
| Sex Steroids Effects on Asthma: A Network Perspective of Immune and Airway Cells. | Cells | 2022 | 35883681 | PubTator, text mining | PubMed |
| Cancer-associated fibroblasts in the single-cell era. | Nat Cancer | 2022 | 35883004 | PubTator, text mining | PubMed |
| Single-cell transcriptome atlas of the human corpus cavernosum. | Nat Commun | 2022 | 35879305 | PubTator, text mining | PubMed |
| Integrative Analysis From Multicenter Studies Identifies a WGCNA-Derived Cancer-Associated Fibroblast Signature for Ovarian Cancer. | Front Immunol | 2022 | 35874760 | PubTator, text mining | PubMed |
| Identifying miRNAs Associated with the Progression of Keloid through mRNA-miRNA Network Analysis and Validating the Targets of miR-29a-3p in Keloid Fibroblasts. | Biomed Res Int | 2022 | 35872873 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4060/papers?page=47